Internal Medicine, Hematology & Oncology · Oklahoma City, OK
NPI
1902137540
Since 2010
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
800 NE 10th St. Okcc 2001-6, Stephenson Cancer Center//University of Oklahoma Health
Oklahoma City, OK, 73104
Phone (405) 272-4022
Groups this clinician bills Medicare through
Medicare paid, 2024
$47K
543 services
Medicare patients, 2024
172
Average age 70
Drug cost, 2024
$1.8M
926 prescriptions
Company payments, 2025
$9,510
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hassan Hatoum was code 99215 (office e&m - established), 293 times for 77 patients. In total Hassan Hatoum billed 543 services in 14 codes, and Medicare paid $47K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 293 | 77 | $99.53 | $29K |
| 99214 Office E&M - Established | Office | 165 | 92 | $59.79 | $9,866 |
| 99222 Hospital E&M - Initial | Facility | 22 | 22 | $97.13 | $2,137 |
| 99205 Office E&M - New | Office | 20 | 20 | $131.88 | $2,638 |
| 99223 Hospital E&M - Initial | Facility | 13 | 13 | $128.79 | $1,674 |
By year: 2022 $79K for 837 services; 2023 $56K for 648 services; 2024 $47K for 543 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hassan Hatoum prescribed most often to Medicare patients was Creon (Lipase/Protease/Amylase), with 68 prescriptions and refills. In total Hassan Hatoum wrote 926 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Creon Lipase/Protease/Amylase | 68 | 71 | 16 | $205K |
| Eliquis Apixaban | 49 | 59 | 13 | $35K |
| Pantoprazole Sodium Generic | 47 | 67 | 17 | $379 |
| Imatinib Mesylate Generic | 38 | 38 | Under 11 | $35K |
| Potassium Chloride Generic | 37 | 43 | 18 | $153 |
| Ondansetron Hcl Generic | 36 | 36 | 29 | $483 |
| Letrozole Generic | 35 | 83 | 17 | $2,176 |
| Prochlorperazine Maleate Generic | 35 | 35 | 26 | $1,125 |
| Everolimus Generic | 32 | 32 | Under 11 | $115K |
| Omeprazole Generic | 32 | 64 | Under 11 | $400 |
| Oxycodone Hcl Generic | 32 | 32 | 17 | $734 |
| Exemestane Generic | 27 | 35 | Under 11 | $721 |
| Lonsurf Trifluridine/Tipiracil Hcl | 25 | 25 | Under 11 | $270K |
| Gabapentin Generic | 23 | 23 | Under 11 | $202 |
| Dexamethasone Generic | 19 | 19 | 12 | $292 |
Brand drugs: - claims; generic drugs: 680 claims; opioid claims: 78.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hassan Hatoum $9,510 ($9,510 in general payments such as food, travel and fees) from 12 companies. The largest payer was Exelixis Inc. with $4,820.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.